97 related articles for article (PubMed ID: 26112935)
1. Assessment of gold nanoparticle effect on prostate cancer LNCaP cells.
Reznikov AG; Salivonyk OA; Sotkis AG; Shuba YM
Exp Oncol; 2015 Jun; 37(2):100-4. PubMed ID: 26112935
[TBL] [Abstract][Full Text] [Related]
2. Development of resveratrol-conjugated gold nanoparticles: interrelationship of increased resveratrol corona on anti-tumor efficacy against breast, pancreatic and prostate cancers.
Thipe VC; Panjtan Amiri K; Bloebaum P; Raphael Karikachery A; Khoobchandani M; Katti KK; Jurisson SS; Katti KV
Int J Nanomedicine; 2019; 14():4413-4428. PubMed ID: 31417252
[No Abstract] [Full Text] [Related]
3. Targeting prostate cancer cells with PSMA inhibitor-guided gold nanoparticles.
Kasten BB; Liu T; Nedrow-Byers JR; Benny PD; Berkman CE
Bioorg Med Chem Lett; 2013 Jan; 23(2):565-8. PubMed ID: 23232055
[TBL] [Abstract][Full Text] [Related]
4. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer.
Chattopadhyay N; Cai Z; Pignol JP; Keller B; Lechtman E; Bendayan R; Reilly RM
Mol Pharm; 2010 Dec; 7(6):2194-206. PubMed ID: 20973534
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro studies of gold nanoparticles loaded with docetaxel.
de Oliveira R; Zhao P; Li N; de Santa Maria LC; Vergnaud J; Ruiz J; Astruc D; Barratt G
Int J Pharm; 2013 Oct; 454(2):703-11. PubMed ID: 23701998
[TBL] [Abstract][Full Text] [Related]
6. Prostate-Specific Membrane Antigen Targeted Gold Nanoparticles for Theranostics of Prostate Cancer.
Mangadlao JD; Wang X; McCleese C; Escamilla M; Ramamurthy G; Wang Z; Govande M; Basilion JP; Burda C
ACS Nano; 2018 Apr; 12(4):3714-3725. PubMed ID: 29641905
[TBL] [Abstract][Full Text] [Related]
7. Extracellular facile biosynthesis, characterization and stability of gold nanoparticles by Bacillus licheniformis.
Singh S; Vidyarthi AS; Nigam VK; Dev A
Artif Cells Nanomed Biotechnol; 2014 Feb; 42(1):6-12. PubMed ID: 23438180
[TBL] [Abstract][Full Text] [Related]
8. Gum Arabic-encapsulated gold nanoparticles for a non-invasive photothermal ablation of lung tumor in mice.
Gamal-Eldeen AM; Moustafa D; El-Daly SM; Abo-Zeid MAM; Saleh S; Khoobchandani M; Katti K; Shukla R; Katti KV
Biomed Pharmacother; 2017 May; 89():1045-1054. PubMed ID: 28298068
[TBL] [Abstract][Full Text] [Related]
9. Homing peptide-conjugated gold nanorods: the effect of amino acid sequence display on nanorod uptake and cellular proliferation.
Alkilany AM; Boulos SP; Lohse SE; Thompson LB; Murphy CJ
Bioconjug Chem; 2014 Jun; 25(6):1162-71. PubMed ID: 24892190
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Membrane-Targeted Gold Nanoparticles Inhibit Cancer Cell Migration and Invasion.
Ali MRK; Wu Y; Ghosh D; Do BH; Chen K; Dawson MR; Fang N; Sulchek TA; El-Sayed MA
ACS Nano; 2017 Apr; 11(4):3716-3726. PubMed ID: 28333438
[TBL] [Abstract][Full Text] [Related]
11. [Procyanidins inhibit proliferation and promote apoptosis of the prostate cancer cell line LNCaP].
Wu ZQ; Huang H; Ding XM; Luo RC
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):499-500. PubMed ID: 17545043
[TBL] [Abstract][Full Text] [Related]
12. Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
Day JM; Tutill HJ; Foster PA; Bailey HV; Heaton WB; Sharland CM; Vicker N; Potter BV; Purohit A; Reed MJ
Mol Cell Endocrinol; 2009 Mar; 301(1-2):251-8. PubMed ID: 18786604
[TBL] [Abstract][Full Text] [Related]
13. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
Gavrilov V; Steiner M; Shany S
Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of galactoxyloglucan-gold nanoparticles against murine ascites and solid carcinoma.
Joseph MM; Aravind SR; George SK; Pillai KR; Mini S; Sreelekha TT
Colloids Surf B Biointerfaces; 2014 Apr; 116():219-27. PubMed ID: 24486833
[TBL] [Abstract][Full Text] [Related]
15. An Overview on Applications of Gold Nanoparticle for Early Diagnosis and Targeted Drug Delivery to Prostate Cancer.
Thambiraj S; Hema S; Shankaran DR
Recent Pat Nanotechnol; 2018; 12(2):110-131. PubMed ID: 29090672
[TBL] [Abstract][Full Text] [Related]
16. Optimization of anti-cancer drugs and a targeting molecule on multifunctional gold nanoparticles.
Rizk N; Christoforou N; Lee S
Nanotechnology; 2016 May; 27(18):185704. PubMed ID: 27004512
[TBL] [Abstract][Full Text] [Related]
17. Bifunctional Au-templated RNA nanoparticles enable direct cell uptake detection and GRP75 knockdown in prostate cancer.
Shah SS; Cultrara CN; Ramos JA; Samuni U; Zilberberg J; Sabatino D
J Mater Chem B; 2020 Mar; 8(10):2169-2176. PubMed ID: 32096520
[TBL] [Abstract][Full Text] [Related]
18. Beyond gold nanoparticles cytotoxicity: Potential to impair metastasis hallmarks.
Pendiuk Gonçalves J; Fraga da Cruz A; Ribeiro de Barros H; Santana Borges B; Almeida Soares de Medeiros LC; Soares MJ; Padovan Dos Santos M; Grassi MT; Chandra A; Del Mercato LL; Rodrigues Rossi G; da Silva Trindade E; Riegel-Vidotti IC; Camargo de Oliveira C
Eur J Pharm Biopharm; 2020 Dec; 157():221-232. PubMed ID: 33130338
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic nanomedicine based on dual-intelligent functionalized gold nanoparticles for cancer imaging and therapy in vivo.
Chen WH; Xu XD; Jia HZ; Lei Q; Luo GF; Cheng SX; Zhuo RX; Zhang XZ
Biomaterials; 2013 Nov; 34(34):8798-807. PubMed ID: 23932289
[TBL] [Abstract][Full Text] [Related]
20. Antiproliferative effects of luteinizing hormone-releasing hormone agonists on the human prostatic cancer cell line LNCaP.
Limonta P; Dondi D; Moretti RM; Maggi R; Motta M
J Clin Endocrinol Metab; 1992 Jul; 75(1):207-12. PubMed ID: 1320049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
